EVENTS

November 12-15, 2025

Now in its 43rd year, the Chemotherapy Foundation Symposium (CFS®) brings together thousands of health care professionals for an exciting 3-day conference that promotes the delivery of evidence-based, state-of-the-art cancer care. Internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering a unique opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize clinical care for your patients with cancer.

November 15, 2025

At the New York Lung Cancers Symposium® attendees will experience a comprehensive overview of multidisciplinary lung cancer treatment. Now in it’s 20th year, this meeting is designed to increase your knowledge of lung cancer therapy, including the roles that surgery, radiology, pulmonology, and pathology play to ensure the most accurate diagnosis of lung cancers. You will hear thought leaders from the New York area discuss optimal approaches for early-stage and locally advanced disease, as well as present the latest data on immunotherapy and targeted agents in metastatic lung cancers. These multidisciplinary interactions will be illustrated in a tumor board format, which will also allow participants to present questions and clinical challenges from their practice.

December 5, 2025, 5:15 PM - 6:15 PM ET

DLL3-Targeting Bispecific Antibodies for Small Cell Lung Cancer – From Innovation to Practice

This program brings together expert faculty to discuss the latest advances and enable the integration of these novel DLL3-targeted agents into ES-SCLC care. Through interactive, case-based discussions with a community oncology colleague, participants will gain practical insights and strategies to navigate emerging efficacy data, anticipate and manage therapy-related toxicities, and address the evolving challenges of patient care in this setting.

March 13, 2026 | New York, NY

PER is proud to partner with the Empire State Hematology & Oncology Society (ESHOS). Now in its 19th year, the annual New York GU™ meeting is dedicated to addressing knowledge and competence gaps arising from the abundance of new data. It focuses on selecting treatments based on patient and tumor characteristics and applying these findings in clinical practice to improve the care of patients with GU malignancies. The program promotes learning through three distinct educational modalities: expert presentations, panel discussions, and interactive tumor board-style case presentations. This unique format has proven highly effective in educating the multidisciplinary physician base on the comprehensive treatment and management of GU cancers.

July 10-11, 2026 | New York, NY

PER is proud to partner with the Empire State Hematology & Oncology Society (ESHOS). The 25th Annual International Congress on the Future of Breast Cancer® East will provide clinicians with cutting-edge updates on recent advances in the treatment of breast cancer, from preclinical breakthroughs to changes in clinical treatment paradigms.

July 11, 2026 | New York, NY

PER is proud to partner with the Empire State Hematology & Oncology Society (ESHOS). Physicians’ Education Resource®, LLC, (PER®) presents the 10th Annual Live Medical Crossfire®: Hematologic Malignancies—a 1-day Medical Crossfire designed to interactively explore the most controversial clinical issues in the field of hematologic malignancies through live, interactive panel discussions with renowned experts. This meeting will contrast viewpoints of key opinion leaders across the country and world regarding emerging clinical data and current standards of practice across liquid tumors.